Executive Series - Bionomics (BNO) CEO & Managing Director, Deborah Rathjen

Online Stockbroker
Tom Piotrowski speaks with Bionomics (BNO) CEO & Managing Director, Deborah Rathjen about clinical trial results of its anxiety drug BNC210 and its Phase 2 trial for managing Post Traumatic Stress Disorder (PTSD)
To view more Executive Series interviews, visit: (VIEW LINK)
2 topics

CommSec is Australia's leading online broker. CommSec has been committed to providing the best in online trading since 1995. CommSec helps make informed investment decisions with comprehensive market research, free live pricing and powerful...
Expertise
No areas of expertise

CommSec is Australia's leading online broker. CommSec has been committed to providing the best in online trading since 1995. CommSec helps make informed investment decisions with comprehensive market research, free live pricing and powerful...
Expertise
No areas of expertise